Search Results - "Weh, Katherine"

Refine Results
  1. 1

    Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis by Cheng, Gang, Zhang, Qi, Pan, Jing, Lee, Yongik, Ouari, Olivier, Hardy, Micael, Zielonka, Monika, Myers, Charles R., Zielonka, Jacek, Weh, Katherine, Chang, Andrew C., Chen, Guoan, Kresty, Laura, Kalyanaraman, Balaraman, You, Ming

    Published in Nature communications (17-05-2019)
    “…Lung cancer often has a poor prognosis, with brain metastases a major reason for mortality. We modified lonidamine (LND), an antiglycolytic drug with limited…”
    Get full text
    Journal Article
  2. 2

    Expression, modulation, and clinical correlates of the autophagy protein Beclin-1 in esophageal adenocarcinoma by Weh, Katherine M., Howell, Amy B., Kresty, Laura A.

    Published in Molecular carcinogenesis (01-11-2016)
    “…Esophageal adenocarcinoma (EAC) is characterized by rapidly increasing incidence and mortality rates and poor survival. Efficacious preventive and treatment…”
    Get full text
    Journal Article
  3. 3

    Cranberries and Cancer: An Update of Preclinical Studies Evaluating the Cancer Inhibitory Potential of Cranberry and Cranberry Derived Constituents by Weh, Katherine M, Clarke, Jennifer, Kresty, Laura A

    Published in Antioxidants (18-08-2016)
    “…Cranberries are rich in bioactive constituents reported to influence a variety of health benefits, ranging from improved immune function and decreased…”
    Get full text
    Journal Article
  4. 4

    Cranberry Polyphenols in Esophageal Cancer Inhibition: New Insights by Weh, Katherine M, Zhang, Yun, Howard, Connor L, Howell, Amy B, Clarke, Jennifer L, Kresty, Laura A

    Published in Nutrients (24-02-2022)
    “…Esophageal adenocarcinoma (EAC) is a cancer characterized by rapidly rising incidence and poor survival, resulting in the need for new prevention and treatment…”
    Get full text
    Journal Article
  5. 5

    Cranberry proanthocyanidins inhibit esophageal adenocarcinoma in vitro and in vivo through pleiotropic cell death induction and PI3K/AKT/mTOR inactivation by Kresty, Laura A, Weh, Katherine M, Zeyzus-Johns, Bree, Perez, Laura N, Howell, Amy B

    Published in Oncotarget (20-10-2015)
    “…Cranberries are rich in bioactive constituents known to improve urinary tract health and more recent evidence supports cranberries possess cancer inhibitory…”
    Get full text
    Journal Article
  6. 6

    Cranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model by Zhang, Yun, Weh, Katherine M, Tripp, Bridget A, Clarke, Jennifer L, Howard, Connor L, Sunilkumar, Shruthi, Howell, Amy B, Kresty, Laura A

    Published in Pharmaceuticals (Basel, Switzerland) (01-12-2023)
    “…We recently reported that cranberry proanthocyanidins (C-PACs) inhibit esophageal adenocarcinoma (EAC) by 83% through reversing reflux-induced bacterial,…”
    Get full text
    Journal Article
  7. 7

    Disparities in Head and Neck Cancer: A Case for Chemoprevention with Vitamin D by Ibrahimovic, Mirela, Franzmann, Elizabeth, Mondul, Alison M, Weh, Katherine M, Howard, Connor, Hu, Jennifer J, Goodwin, W Jarrard, Kresty, Laura A

    Published in Nutrients (29-08-2020)
    “…Blacks experience disproportionate head and neck cancer (HNC) recurrence and mortality compared to Whites. Overall, vitamin D status is inversely associated to…”
    Get full text
    Journal Article
  8. 8

    Proanthocyanidins mitigate bile acid‐induced changes in GSTT2 levels in a panel of racially diverse patient‐derived primary esophageal cell cultures by Weh, Katherine M., Turgeon, Danielle K., Rubenstein, Joel H., Clarke, Jennifer L., Howell, Amy B., Chang, Andrew C., Kresty, Laura A.

    Published in Molecular carcinogenesis (01-03-2022)
    “…Persistent and symptomatic reflux of gastric and duodenal contents, known as gastroesophageal reflux disease (GERD), is the strongest risk factor for…”
    Get full text
    Journal Article
  9. 9

    Characterizing isoform switching events in esophageal adenocarcinoma by Zhang, Yun, Weh, Katherine M., Howard, Connor L., Riethoven, Jean-Jack, Clarke, Jennifer L., Lagisetty, Kiran H., Lin, Jules, Reddy, Rishindra M., Chang, Andrew C., Beer, David G., Kresty, Laura A.

    Published in Molecular therapy. Nucleic acids (13-09-2022)
    “…Isoform switching events with predicted functional consequences are common in many cancers, but characterization of switching events in esophageal…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Rod photoreceptor-specific deletion of cytosolic aspartate aminotransferase, GOT1, causes retinal degeneration by Subramanya, Shubha, Goswami, Moloy T, Miller, Nicholas, Weh, Eric, Chaudhury, Sraboni, Zhang, Li, Andren, Anthony, Hager, Heather, Weh, Katherine M, Lyssiotis, Costas A, Besirli, Cagri G, Wubben, Thomas J

    Published in Frontiers in ophthalmology (2023)
    “…Photoreceptor cell death is the cause of vision loss in many forms of retinal disease. Metabolic dysfunction within the outer retina has been shown to be an…”
    Get full text
    Journal Article
  12. 12

    Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome by Weh, Katherine M, Howard, Connor L, Zhang, Yun, Tripp, Bridget A, Clarke, Jennifer L, Howell, Amy B, Rubenstein, Joel H, Abrams, Julian A, Westerhoff, Maria, Kresty, Laura A

    Published in JCI insight (08-02-2024)
    “…The gut and local esophageal microbiome progressively shift from healthy commensal bacteria to inflammation-linked pathogenic bacteria in patients with…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Abstract 2593: Racially diverse primary esophageal cell cultures for evaluating mitigation of bile-induced injury by Weh, Katherine M., Turgeon, Danielle K., Howell, Amy, Kresty, Laura A.

    Published in Cancer research (Chicago, Ill.) (01-07-2021)
    “…Persistent and symptomatic reflux of gastric and duodenal contents, known as gastroesophageal reflux disease (GERD), is the strongest risk factor for EAC…”
    Get full text
    Journal Article
  15. 15

    Abstract 5077: Proteomic profiling reveals chemopreventive targets in esophageal adenocarcinoma by Weh, Katherine M., Howard, Connor L., Howell, Amy B., Clarke, Jennifer L., Kresty, Laura A.

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…Esophageal adenocarcinoma (EAC) is characterized by rising incidence rates and high mortality due to late stage diagnosis and a lack of efficacious options for…”
    Get full text
    Journal Article
  16. 16

    Abstract 6588: Omics integration provides insight into esophageal cancer inhibitory mechanisms of a cranberry extract by Weh, Katherine M., Howard, Connor L., Tripp, Bridget A., Clarke, Jennifer L., Howell, Amy B., Kresty, Laura A.

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Our laboratory studies chemoprevention of esophageal adenocarcinoma (EAC) through utilization of the rat esophagogastroduodenal anastomosis (EGDA) surgical…”
    Get full text
    Journal Article
  17. 17

    Abstract 1418: Proanthocyanidins enhance chemotherapy-induced esophageal adenocarcinoma cell death by Zhang, Yun, Weh, Katherine, Howard, Connor, Lagisetty, Kiran, McEwen, Dyke, Lin, Jules, Reddy, Rishindra M., Chang, Andrew, Beer, David G., Howell, Amy, Kresty, Laura A.

    Published in Cancer research (Chicago, Ill.) (01-07-2021)
    “…Esophageal adenocarcinoma (EAC) is a devastating cancer characterized by rising incidence and poor prognosis. The five-year survival rate is 20% due to late…”
    Get full text
    Journal Article
  18. 18

    Abstract PR001: Mechanisms by which Mito-LND inhibits KRAS mutant lung cancer by Weh, Katherine M., Howard, Connor L., Zhang, Yun, Riethoven, Jean-Jack, Clarke, Jennifer L., Kalyanaraman, Balaraman, You, Ming, Kresty, Laura A.

    “…Lung cancer remains the most frequently diagnosed cancer and leading cause of cancer mortality in the United States and worldwide. Efficacious targeted options…”
    Get full text
    Journal Article
  19. 19

    Abstract 5250: Cranberry proanthocyanidins reverse microbial dysbiosis and inhibit bile acid metabolism in association with esophageal cancer prevention by Weh, Katherine M., Salzman, Nita H., Howell, Amy B., Clarke, Jennifer L., Tripp, Bridget A., Kresty, Laura A.

    Published in Cancer research (Chicago, Ill.) (01-07-2017)
    “…Our laboratory has been investigating the cancer inhibitory potential of cranberry proanthocyanidins (C-PAC) against esophageal adenocarcinoma (EAC), a cancer…”
    Get full text
    Journal Article
  20. 20

    Abstract 279: Cranberry proanthocyanidins mitigate reflux-induced transporter dysregulation in esophageal adenocarcinoma by Weh, Katherine M., Tripp, Bridget A., Clarke, Jennifer L., Howell, Amy B., Lin, Jules, Beer, David G., Chang, Andrew C., Kresty, Laura A.

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…Esophageal adenocarcinoma (EAC) incidence rates have increased sharply (>500%) throughout the Westernized world since the 1980s, despite the widespread use of…”
    Get full text
    Journal Article